Wednesday, February 3, 2010

BRIEF: Teva favorite as Pfizer quits Ratiopharm race: The development leaves Teva bidding against Actavis for the German pharmac

BRIEF: Teva favorite as Pfizer quits Ratiopharm race: The development leaves Teva bidding against Actavis for the German pharmac


read more

http://digg.com/u1MIBJ
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)